Your browser doesn't support javascript.
loading
Combination treatment of renal cell carcinoma with belinostat and 5-fluorouracil: a role for oxidative stress induced DNA damage and HSP90 regulated thymidine synthase.
Kim, Mi Joung; Lee, Jee Suk; Park, Sang Eun; Yi, Hye-Jin; Jeong, In Gab; Kang, Jong Soon; Yun, Jieun; Lee, Joo-Yong; Ro, Seonggu; Lee, Jung Shin; Choi, Eun Kyung; Hwang, Jung Jin; Kim, Choung-Soo.
Afiliación
  • Kim MJ; Institute for Innovative Cancer Research, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Lee JS; Institute for Innovative Cancer Research, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Park SE; Institute for Innovative Cancer Research, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea; Department of Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Yi HJ; Institute for Innovative Cancer Research, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Jeong IG; Institute for Innovative Cancer Research, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea; Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Kang JS; Bio-Evaluation Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea.
  • Yun J; Bio-Evaluation Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea.
  • Lee JY; Department of Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea; Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Ro S; CrystalGenomics, Inc., Gyeonggi-Do, Republic of Korea.
  • Lee JS; Institute for Innovative Cancer Research, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea; Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Choi EK; Institute for Innovative Cancer Research, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea; Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea; Center for Development and Commercialization of
  • Hwang JJ; Institute for Innovative Cancer Research, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea; Department of Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea; Asan Institute for Life Sciences, Asan Medical Center, Uni
  • Kim CS; Institute for Innovative Cancer Research, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea; Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. Electronic address: cskim@amc.seoul.kr.
J Urol ; 193(5): 1660-8, 2015 May.
Article en En | MEDLINE | ID: mdl-25433307

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sulfonamidas / Timidilato Sintasa / Daño del ADN / Carcinoma de Células Renales / Protocolos de Quimioterapia Combinada Antineoplásica / Estrés Oxidativo / Proteínas HSP90 de Choque Térmico / Inhibidores de Histona Desacetilasas / Fluorouracilo / Ácidos Hidroxámicos Límite: Animals / Humans Idioma: En Año: 2015 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sulfonamidas / Timidilato Sintasa / Daño del ADN / Carcinoma de Células Renales / Protocolos de Quimioterapia Combinada Antineoplásica / Estrés Oxidativo / Proteínas HSP90 de Choque Térmico / Inhibidores de Histona Desacetilasas / Fluorouracilo / Ácidos Hidroxámicos Límite: Animals / Humans Idioma: En Año: 2015 Tipo del documento: Article